GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hester Biosciences Ltd (BOM:524669) » Definitions » Scaled Net Operating Assets

Hester Biosciences (BOM:524669) Scaled Net Operating Assets : 0.00 (As of Dec. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Hester Biosciences Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hester Biosciences's operating assets for the quarter that ended in Dec. 2024 was ₹0 Mil. Hester Biosciences's operating liabilities for the quarter that ended in Dec. 2024 was ₹0 Mil. Hester Biosciences's Total Assets for the quarter that ended in Sep. 2024 was ₹6,693 Mil. Therefore, Hester Biosciences's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.00.


Hester Biosciences Scaled Net Operating Assets Historical Data

The historical data trend for Hester Biosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hester Biosciences Scaled Net Operating Assets Chart

Hester Biosciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.03 0.84 1.14 0.98 0.80

Hester Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Hester Biosciences's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Hester Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hester Biosciences's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hester Biosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hester Biosciences's Scaled Net Operating Assets falls into.


;
;

Hester Biosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hester Biosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(6493.52-1150.94)/6699.66
=0.80

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=6623.47 - 129.95
=6493.52

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3594.72 - 1871.09 - 572.69
=1150.94

Hester Biosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(0-0)/6692.5
=0.00

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0 - 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hester Biosciences Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hester Biosciences's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hester Biosciences Business Description

Traded in Other Exchanges
Address
Motilal Hirabhai Road, Pushpak, 1st Floor, Panchvati Circle, Ahmedabad, GJ, IND, 380006
Hester Biosciences Ltd is an India based animal healthcare company. The company's operating segment includes Poultry Healthcare, Animal Healthcare, Petcare and Others. It generates maximum revenue from the Poultry Healthcare segment. The company's products are used to cure poultry diseases such as Fowl Pox, Newcastle Disease, Infectious Bronchitis and others. Geographically, it sells the products in India and also exports them to other countries, of which key revenue is derived from India.

Hester Biosciences Headlines

No Headlines